It is important to note that the level of NfL is a good marker of severity: its level is indeed correlated with a poor prognosis in many neurodegenerative diseases (ALS, Parkinson’s disease syndromes, MS, Huntington’s,..). This evidence concerns the gene NEFL and myeloid sarcoma.